Immediate Impact
58 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Regulation of cGAS–STING signalling and its diversity of cellular outcomes
2025 Standout
Works of Ryan J. Brisson being referenced
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
2018
Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ryan J. Brisson | 259 | 323 | 225 | 39 | 539 | |
| Tamara Rordorf | 370 | 205 | 169 | 36 | 605 | |
| Chi‐Chung Tong | 261 | 274 | 223 | 31 | 567 | |
| Mackenzie Daly | 233 | 310 | 208 | 37 | 554 | |
| Xue-Song Sun | 260 | 361 | 187 | 49 | 584 | |
| Corey C. Foster | 229 | 218 | 193 | 38 | 628 | |
| Shachi Jenny Sharma | 165 | 301 | 230 | 41 | 515 | |
| Gideon Marshak | 225 | 282 | 290 | 24 | 564 | |
| Julius Moratin | 217 | 180 | 156 | 53 | 470 | |
| Masamune Takeda | 294 | 289 | 214 | 26 | 513 | |
| Matthew E. Witek | 207 | 124 | 170 | 49 | 559 |
All Works
Login with ORCID to disown or claim papers
Loading papers...